New research shows where in the brain the earliest signs of Alzheimer's occur

November 1, 2017
PET scan of a human brain with Alzheimer's disease. Credit: public domain

Researchers at Lund University in Sweden have for the first time convincingly shown where in the brain the earliest signs of Alzheimer's occur. The discovery could potentially become significant to future Alzheimer's research while contributing to improved diagnostics.

In Alzheimer's, the initial changes in the occur through retention of the protein, β-amyloid (beta-amyloid). The process begins 10-20 years before the first symptoms become noticeable in the patient.

In Nature Communications, a research team headed by Professor Oskar Hansson at Lund University has now presented results showing where in the brain the initial accumulation of β-amyloid occurs. It is in the inner parts of the brain, within one of the brain's most important functional networks - known as the .

"A big piece of the puzzle in Alzheimer's research is now falling into place. We previously did not know where in the brain the earliest stages of the disease could be detected. We now know which parts of the brain are to be studied to eventually explain why the disease occurs", says Sebastian Palmqvist, associate professor at Lund University and physician at Skåne University Hospital.

The default mode network is one of several networks, each of which has a different function in the brain. It is most active when we are in an awake quiescent state without interacting with the outside world, for example, when daydreaming. The network belongs to the more advanced part of the brain. Among other things, it processes and links information from lower systems.

The study, conducted in collaboration with Michael Schöll, associate senior lecturer at the University of Gothenburg, and William Jagust, professor at the University of California, is based on data from more than 400 people in the United States who have an increased risk of developing Alzheimer's, and about as many participants from the Swedish research project, BioFINDER. The brain status of all the participants was monitored for two years, and compared to a control group without any signs of Alzheimer's.

The difficulty of determining which individuals are at risk of developing dementia later in life, in order to subsequently monitor them in research studies, has been an obstacle in the research world. The research team at Lund University has therefore developed a unique method to identify, at an early stage, which individuals begin to accumulate β-amyloid and are at risk.

The method combines cerebrospinal fluid test results with PET scan brain imaging. This provides valuable information about the brain's tendency to accumulate β-amyloid.

In addition to serving as a roadmap for future research studies of Alzheimer's disease, the new results also have a clinical benefit:

"Now that we know where Alzheimer's disease begins, we can improve the diagnostics by focusing more clearly on these parts of the brain, for example in medical imaging examinations with a PET camera", says Oskar Hansson, professor at Lund University, and medical consultant at Skåne University Hospital.

Although the first symptoms of Alzheimer's become noticeable to others much later, the current study shows that the brain's communication activity changes in connection with the early retention of β-amyloid. How, and with what consequences, will be examined by the research team in further studies.

The current study was funded by the European Research Council (ERC), the Swedish Research Council (VR), the Swedish Alzheimer's Foundation and Region of Skåne (through ALF funding).

Explore further: New possibility of studying how Alzheimer's disease affects the brain at different ages

More information: Sebastian Palmqvist et al. Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity, Nature Communications (2017). DOI: 10.1038/s41467-017-01150-x

Related Stories

New possibility of studying how Alzheimer's disease affects the brain at different ages

August 31, 2017
Alzheimer's disease can lead to several widely divergent symptoms and, so far, its various expressions have mainly been observed through the behaviour and actions of patients. Researchers at Lund University in Sweden have ...

Alzheimer's more versatile than previously known

March 7, 2016
Accumulation of the substance amyloid beta in the brain impairs the memory and cognitive ability in people with Alzheimer's. New findings from Lund University in Sweden show that the cause of amyloid beta pathology might ...

Sleep and Alzheimer's disease connection

October 17, 2017
How often do you get a good night's sleep? Centers for Disease Control and Prevention guidelines recommend adults get an average of at least seven hours of sleep a night. Dr. Ronald Petersen, a Mayo Clinic neurologist, says ...

New brain visualisation of Alzheimer's at different ages holds out hope for faster diagnosis and treatment

September 28, 2017
As Alzheimer's disease is associated with a wide variety of symptoms, usually observed through patients' behaviour and actions, effective and timely treatment has proven elusive. An EU-funded project has contributed towards ...

Increased chances for early detection of Alzheimer's disease

September 22, 2015
A method for detecting early signs of Alzheimer's disease using amyloid PET imaging works as well as the previously used cerebrospinal fluid sample method. This is the conclusion of a new Lund University study—the most ...

New imaging technique in Alzheimer's disease opens up possibilities for drug development

September 28, 2016
Tau PET is a new and promising imaging method for Alzheimer's disease. A case study from Lund University in Sweden now confirms that tau PET images correspond to a higher degree to actual changes in the brain. According to ...

Recommended for you

Dementia with Lewy bodies: Unique genetic profile identified

December 15, 2017
Dementia with Lewy bodies has a unique genetic profile, distinct from those of Alzheimer's disease or Parkinson's disease, according to the first large-scale genetic study of this common type of dementia.

Major cause of dementia discovered

December 11, 2017
An international team of scientists have confirmed the discovery of a major cause of dementia, with important implications for possible treatment and diagnosis.

Canola oil linked to worsened memory and learning ability in Alzheimer's

December 7, 2017
Canola oil is one of the most widely consumed vegetable oils in the world, yet surprisingly little is known about its effects on health. Now, a new study published online December 7 in the journal Scientific Reports by researchers ...

Genetics study suggests that education reduces risk of Alzheimer's disease

December 7, 2017
The theory that education protects against Alzheimer's disease has been given further weight by new research from the University of Cambridge, funded by the European Union. The study is published today in the BMJ.

Healthy mitochondria could stop Alzheimer's

December 6, 2017
Alzheimer's disease is the most common form of dementia and neurodegeneration worldwide. A major hallmark of the disease is the accumulation of toxic plaques in the brain, formed by the abnormal aggregation of a protein called ...

Alzheimer's damage in mice reduced with compound that targets APOE gene

December 6, 2017
People who carry the APOE4 genetic variant face a substantial risk for developing Alzheimer's disease.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

BubbaNicholson
1 / 5 (2) Nov 01, 2017
The first areas are all on pheromone reception/association pathways. Perhaps Sebastian's team should include someone familiar with neuroanatomy and physiology? Alzheimer's Disease is pheromonal in origin, nothing could be clearer. Indeed 250mg of healthy adult male facial skin surface lipid p.o. halts progression of the disease and initiates behavioral recovery. Patients with loss of facial expression started to laugh again. As always, extreme measures must be taken to avoid the vapors: fans, negative air pressure, patient isolation, respirators, fume hoods, etc.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.